Related Experiment Video
Updated: Jan 20, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
An Updated Review of Disulfiram: Molecular Targets and Strategies for Cancer Treatment
Qingzhu Yang1, Yao Yao1, Kai Li1
1School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Abstract:
Repurposing already approved drugs as new anticancer agents is a promising strategy considering the advantages such as low costs, low risks and less time-consumption. Disulfiram (DSF), as the first drug for antialcoholism, was approved by the U.S. Food and Drug Administration (FDA) over 60 years ago. Increasing evidence indicates that DSF has great potential for the treatment of various human cancers. Several mechanisms and targets of DSF related to cancer therapy have been proposed, including the inhibition of ubiquitin-proteasome system (UPS), cancer cell stemness and cancer metastasis, and alteration of the intracellular reactive oxygen species (ROS). This article provides a brief review about the history of the use of DSF in humans and its molecular mechanisms and targets of anticancer therapy, describes DSF delivery strategies for cancer treatment, summarizes completed and ongoing cancer clinical trials involving DSF, and offers strategies to better use DSF in cancer therapies.
Insights
Repurposing the antialcoholism drug Disulfiram (DSF) shows promise for cancer treatment. This review explores DSF
Area of Science:
- Oncology and Pharmacology
Background:
- Repurposing approved drugs like Disulfiram (DSF) offers a cost-effective and time-efficient approach to cancer therapy.
- DSF, an antialcoholism medication approved by the FDA over 60 years ago, exhibits significant potential in treating various human cancers.
Purpose of the Study:
- To review the history and molecular mechanisms of Disulfiram (DSF) in anticancer therapy.
- To explore DSF delivery strategies and summarize clinical trial data for cancer treatment.
- To propose strategies for optimizing DSF utilization in oncology.
Main Methods:
- Literature review of Disulfiram's (DSF) history, anticancer mechanisms, and clinical applications.
- Analysis of proposed molecular targets including the ubiquitin-proteasome system (UPS), cancer stemness, metastasis, and reactive oxygen species (ROS).
- Summary of completed and ongoing clinical trials involving DSF in cancer patients.
Main Results:
- Disulfiram (DSF) demonstrates anticancer potential through multiple mechanisms, including UPS inhibition and modulation of ROS.
- Evidence suggests DSF can target cancer stemness and inhibit metastasis.
- Clinical trials are evaluating DSF's efficacy and safety across various cancer types.
Conclusions:
- Disulfiram (DSF) is a promising repurposed drug for cancer therapy with a well-established safety profile.
- Further research and clinical trials are essential to optimize DSF delivery and treatment strategies for enhanced anticancer efficacy.
- DSF holds potential for integration into diverse cancer treatment regimens.
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Molecular Models

